Review Article
Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review
Table 1
Inflammatory markers in iNPH patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑↑ = most evidence: significantly increased in iNPH patients in two or more studies, and maximum one study reports a contradictory result. ↑ = limited evidence: significantly increased in iNPH patients in a single study. ↓ = limited evidence: significantly decreased in iNPH patients in a single study. → → = most evidence: no significant difference in two or more studies, and maximum one study reports a contradictory result. → = no significant difference in a single study. Contr = contradicting results. Abbreviations: IL: interleukin; LRG: leucine-rich α2-glycoprotein; SP-G: surfactant protein-G; TβR-II: transforming growth factor beta type II receptor; TIMP: tissue inhibitor of metalloproteinases; TNF: tumor necrosis factor; CCL: C-C motif chemokine ligand; MCP: monocyte chemoattractant protein; sCD40: soluble CD40 ligand; MMP: matrix metalloproteinase; TGF: transforming growth factor; YKL40: chitinase-3-like protein. |